![]() We conducted a retrospective pharmacogenetic study to examine remdesivir-associated liver enzyme elevation among Million Veteran Program participants hospitalized with COVID-19 between March 15, 2020, and June 30, 2021. Remdesivir is the first US Food and Drug Administration (FDA)-approved drug for the treatment of coronavirus disease 2019 (COVID-19). 14 Department of Epidemiology and Biostatistics, University of Arizona, Tucson, Arizona, USA.13 Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.12 Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.11 Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.10 School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.9 VA Portland Health Care System, Portland, Oregon, USA.8 Cardiology Section, VA Boston Healthcare System and Cardiovascular Division, Brigham & Women's Hospital, Boston, Massachusetts, USA. ![]() 7 VA Boston Healthcare System, Boston, Virginia, USA.6 VA Informatics and Computing Infrastructure (VINCI), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA.5 Durham VA Healthcare System and Duke University School of Medicine, Durham, North Carolina, USA.4 VA San Diego Healthcare System and Division of Gastroenterology, University of California San Diego, San Diego, California, USA. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |